Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carbamazepine 100mg tablets
0408010C0AAABAB
|
Carbamazepine | Carbamazepine | Central Nervous System | 59,777 |
|
Carbamazepine 200mg tablets
0408010C0AAACAC
|
Carbamazepine | Carbamazepine | Central Nervous System | 57,672 |
|
Carbamazepine 400mg tablets
0408010C0AAADAD
|
Carbamazepine | Carbamazepine | Central Nervous System | 24,446 |
|
Carbamazepine 200mg modified-release tablets
0408010C0AAAGAG
|
Carbamazepine | Carbamazepine | Central Nervous System | 20,039 |
|
Carbamazepine 400mg modified-release tablets
0408010C0AAAHAH
|
Carbamazepine | Carbamazepine | Central Nervous System | 14,817 |
|
Carbamazepine 100mg/5ml oral suspension sugar free
0408010C0AAAPAP
|
Carbamazepine | Carbamazepine | Central Nervous System | 14,380 |
|
Carbamazepine 250mg suppositories
0408010C0AAAVAV
|
Carbamazepine | Carbamazepine | Central Nervous System | 76 |
|
Carbamazepine 500mg/5ml oral suspension
0408010C0AAAYAY
|
Carbamazepine | Carbamazepine | Central Nervous System | 28 |
|
Carbamazepine 125mg suppositories
0408010C0AAAUAU
|
Carbamazepine | Carbamazepine | Central Nervous System | 22 |
|
Carbamazepine 100mg/5ml oral liquid
0408010C0AABDBD
|
Carbamazepine | Carbamazepine | Central Nervous System | 14 |
|
Carbamazepine 200mg/5ml oral liquid
0408010C0AAAXAX
|
Carbamazepine | Carbamazepine | Central Nervous System | 5 |
|
Carbamazepine 100mg chewable tablets sugar free
0408010C0AAAJAJ
|
Carbamazepine | Carbamazepine | Central Nervous System | 2 |
|
Carbamazepine 120mg/5ml oral liquid
0408010C0AABFBF
|
Carbamazepine | Carbamazepine | Central Nervous System | 1 |
|
Carbamazepine 10mg/5ml oral liquid
0408010C0AABGBG
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 200mg chewable tablets sugar free
0408010C0AAAKAK
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 35mg/5ml oral liquid
0408010C0AABEBE
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 40mg/5ml oral suspension
0408010C0AABHBH
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
|
Carbamazepine 50mg/5ml oral solution
0408010C0AABIBI
|
Carbamazepine | Carbamazepine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.